ENOV
Enovis Corporation · Healthcare · Medical - Devices
Señales de momentum (gestores comparables):
amplitud de titulares +18.2% ·
flujo de acciones -9.1% ·
nuevas posiciones netas +15.4%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 92 | +1 | 44.85M | $923.90M | +11 | −10 |
| Q1 2026 | 94 | 0 | 43.44M | $983.72M | +7 | −7 |
| Q4 2025 | 94 | 0 | 46.98M | $1.22B | +1 | −1 |
| Q3 2025 | 15 | 0 | 23.49M | $712.80M | +1 | −1 |
| Q2 2025 | 12 | -1 | 21.15M | $663.36M | +1 | −2 |
| Q1 2025 | 10 | -3 | 4.37M | $166.84M | +1 | −4 |
| Q4 2024 | 13 | +2 | 4.81M | $211.07M | +3 | −1 |
| Q3 2024 | 10 | 0 | 3.56M | $153.33M | +1 | −1 |
| Q2 2024 | 10 | — | 3.60M | $162.77M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 1.73M | — | $76.02M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (pasivo) | 1.73M | — | $76.02M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 994.28K | +263.2% | $43.63M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 994.28K | +263.2% | $43.63M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 923.67K | +0.2% | $40.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 923.67K | +0.2% | $40.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Millennium Management ✦ | 572.58K | -69.5% | $25.12M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 572.58K | -69.5% | $25.12M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 250.00K | Nuevo | $10.97M | 0.0% | New | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 141.53K | Nuevo | $6.21M | 0.0% | New | 1 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 63.55K | Nuevo | $2.79M | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 56.60K | +180.8% | $2.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 56.60K | +180.8% | $2.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 56.60K | +180.8% | $2.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 56.60K | +180.8% | $2.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 38.75K | -84.7% | $1.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | PRIMECAP Management ✦ | 11.97K | -86.0% | $525,112 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 9.85K | -89.9% | $432,174 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 8.83K | +10.1% | $387,373 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Bridgewater Associates ✦ | 5.92K | -66.4% | $259,550 | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Adage Capital Partners | $10.97M | 0.0% |
| Marshall Wace | $6.21M | 0.0% |
| Point72 Asset Management | $2.79M | 0.0% |
Posición cerrada
| Two Sigma Investments | $204,186 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 4 tenedores, 12.22M acciones, $11.78M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.